Navigation Links
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego

SAN DIEGO, Sept. 4 /PRNewswire/ -- Takeda San Diego announced today that Keith Wilson, Ph.D. has been named president and chief scientific officer (CSO). In this position, he is responsible for overseeing all activities related to Takeda San Diego, Takeda Pharmaceutical Company Limited's U.S.-based drug discovery company.

"Dr. Wilson has been an important part of Takeda San Diego for several years and brings a wealth of scientific excellence to Takeda," said Shigenori Ohkawa, Ph.D., general manager, pharmaceutical research division, Takeda Pharmaceutical Company Limited. "His leadership has been instrumental in focusing the company on drug discovery and building the Takeda San Diego pipeline, and we look forward to his vital contributions in this new role."

Before being named president and CSO at Takeda San Diego, Dr. Wilson served dual roles as vice president of structural biology and vice president of business development. Prior to joining Takeda, he also spent a decade with Vertex Pharmaceuticals co-leading drug discovery programs and significant alliance projects.

Dr. Wilson has formal training in protein X-ray crystallography, and has a doctorate degree in physics from the University of Oregon and a bachelor's degree in physics from Colby College, where he graduated magna cum laude and was awarded the William A. Rogers prize in physics. Dr. Wilson is a contributing author on more than 30 peer-reviewed publications and co-inventor of six issued U.S. patents covering multiple drug candidates.

About Takeda San Diego, Inc.

Takeda San Diego is Takeda's first U.S.-based discovery research operation. Takeda San Diego achieves an advantage in drug discovery by leveraging its leading structural biology capabilities to determine the three dimensional structures of drug targets ahead of competitors and then uses these structures to efficiently create best-in-class drug candidates to treat diabetes, cancer, and other important diseases. Visit to learn more.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website,

SOURCE Takeda Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. CEO Wilson Defines GEs Health-IT Customer
2. Bruce Maas named CIO at UW-Milwaukee
3. Three finalists named for UW-Madison CIO
4. Eight lawmakers named to Speakers IT task force
5. Hospital named for Madame Curie installs TomoTherapy system
6. Two UW-Madison professors named to National LambdaRail Networking Research Council
7. UW researcher named top innovator
8. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
9. Inacom named Microsofts favorite learning solutions partner of the year
10. Five Wisconsin CIOs named top in nation
11. Deltanoid named to top-15 list of biotech companies
Post Your Comments:
(Date:11/30/2015)... -- HUYA Bioscience International, the leader in accelerating global development ... announced it has signed a Memorandum of Understanding with ... between KDDF and HUYA with the ultimate goal of ... the global market. China,s ... preclinical and clinical stage compounds. The company advances the ...
(Date:11/30/2015)... Jose, CA (PRWEB) , ... ... ... Content Intelligence Company, today announced tighter software integration with MarkLogic, the Enterprise ... where organizations maximize information to drive change. , Smartlogic’s Content Intelligence capabilities ...
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... la première fois les différences entre les souches ... de celles des êtres humains . Ces ... comprendre et envisager la prise en charge efficace de ... ent diagnostiqués chez les chats .    --> ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... , October 27, 2015 ... Semantic Gaze Mapping technology (ASGM) automatically maps data from ... Tracking Glasses , so that they can be ... --> Munich, Germany , October 28-29, ... maps data from mobile eye tracking videos created with ...
(Date:10/23/2015)... Research and Markets ( ) has ... Biometrics Market 2015-2019" report to their offering. ... global voice recognition biometrics market to grow at a ... --> --> The report, Global Voice ... an in-depth market analysis with inputs from industry experts. ...
Breaking Biology News(10 mins):